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Abstract 
The combination of field asymmetric waveform ion mobility spectrometry with liquid 
chromatography-mass spectrometry (LC-FAIMS-MS) has been developed for the 
analysis of glucuronide and sulfate metabolites of seven anabolic-androgenic 
steroids AAS in urine. Separation by FAIMS-MS was investigated in positive ion 
mode for selected cationic adducts (H+, NH4+, Na+, K+, Cs+). LC-FAIMS-MS analysis 
of the doubly sodiated adducts ([M+2Na-H]+) of isobaric and co-eluting steroid 
metabolites allowed their rapid (8 min) qualitative and quantitative determination in 
spiked urine using hydrophilic interaction liquid chromatography prior to FAIMS-MS 
separation, with discrimination >95% achieved between the steroids investigated. A 
quantitative evaluation of the LC-FAIMS-MS method was performed giving limits of 
detection in the range 1-6 ng mL-1, limits of quantification in the range 3-20 ng mL-1, 
with reproducibility (%RSD <10%; n=6) and linearity (R2> 0.99). The LC-FAIMS-MS 
method demonstrates increases in signal-to-noise ratios for the doubly sodiated 
steroid metabolites in unspiked urine (>250%) by the reduction of isobaric 
interferences from the matrix. An alternative or additional tool for identification of the 
steroid metabolites is based on the observations of different patterns of sodium 
acetate clusters that are characteristic for each metabolite.  
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Introduction 
The determination of anabolic androgenic steroids (AAS), either as free drugs or 
their glucuronide or sulfate metabolites, has conventionally used mass spectrometric 
based techniques including gas chromatography-mass spectrometry (GC-MS) and 
liquid chromatography-mass spectrometry (LC-MS).1 GC-MS remains the method of 
choice for targeted quantitative analysis of endogenous AAS (EAAS) and the ratios 
of their naturally-occurring isomers.2 The detection of EAAS is complicated by their 
natural presence in the body, which means the simple presence of these steroids 
and/or their metabolites cannot be used to prove administration. Population derived 
thresholds of steroid concentrations for detecting EAAS administration are limited in 
their sensitivity due to the large inter-individual variations, differences in the relative 
concentrations of the steroids to each other, the influence of urinary dilution, and the 
effect of confounding factors. For example, a study of over 3000 individuals found 
that in males (with concentrations typically higher than females) the mean 
concentrations for androsterone and etiocholanolone were 2640 ng mL-1 (max 
20,700 ng mL-1) and 1850 ng mL-1 (11,400 ng mL-1) respectively.3 For testosterone 
and epitestosterone the concentrations were much lower, 37.4 ng mL-1 (max 249 ng 
mL-1) and 28.9 ng mL-1 (max 391 ng mL-1). 
GC-MS may be the current method of choice for EAAS analysis, however, 
shortcomings of GC-MS are the need for derivatisation of the steroids prior to 
analysis,4 and long analysis times to resolve isobaric species. LC-MS does not 
usually require a derivatization step and can be used to enhance the speed of 
analysis with shorter chromatographic run times compared to GC-MS.4 Further 
specificity and sensitivity can be achieved by combining both chromatographic 
methodologies with tandem mass spectrometry (MS/MS) in targeted analysis.5,6 
However, limitations of this approach include the inability to separate isobaric 
interferences by MS with similar retention times, and the identification of isobaric 
steroids with similar fragmentation patterns using MS/MS.  
Ion mobility spectrometry (IMS) is an orthogonal separation technique that has been 
shown to be a powerful tool for distinguishing isomers of many different biological 
classes, including metabolites,7,8 peptides,9 lipids,10 and carbohydrates. IMS has 
also been shown to reduce chemical noise due to isobaric interferences in biological 
matrices when combined with LC- MS (and MS/MS).7,12,13 Established IMS 
techniques include static field drift tube IMS (DTIMS) and travelling wave IMS 
(TWIMS) systems, in which ions are separated on the basis of their velocity through 
the device in the presence of a buffer gas, the velocity being related to ion size and 
shape (collision cross section).  
Field asymmetric waveform ion mobility spectrometry (FAIMS), also known as 
differential ion mobility spectrometry (DMS), is a gas-phase ion separation technique 
which separates ions based upon compound differences in the mobility of an ion 
through an alternating RF waveform, known as the dispersion field (DF), of high and 
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low electric field strengths. A small DC voltage, known as the compensation field 
(CF), is used to correct ion trajectory allowing selected ions to pass through the 
device. The CF can be scanned at fixed DF in order to produce a FAIMS spectrum.  
FAIMS has a high degree of orthogonality to both MS and LC, and has been shown 
to separate steroid isomers and isobars, whilst also increasing signal-to-noise ratios 
(S:N) for targeted compounds by removing isobaric interferences from biological 
matrices, such as plasma and urine.14-16 However, some of these reported studies 
required derivatisation prior to IMS or FAIMS analysis to achieve separation of the 
steroid isomers of interest.12,16 Here, we describe an LC-FAIMS-MS method using a 
miniaturized FAIMS device for the determination in urine of seven steroid 
metabolites of interest to anti-doping.17 The steroids targeted (Figure 1) include 
isobaric steroid sulfates: testosterone sulfate (TS), epitestosterone sulfate (ETS), 
and dehydroepiandrosterone sulfate (DHEAS); and two pairs of isobaric steroid 
glucuronides: testosterone glucuronide (TG), epitestosterone glucuronide (ETG) and 
androsterone glucuronide (ADG), etiocholanolone glucuronide (ECG). These pairs of 
steroid glucuronides and trio of steroid sulfate metabolites are exact mass isomers 
which cannot be separated by even the highest resolution mass spectrometry. The 
data presented here includes a FAIMS-MS investigation into the separation of the 
steroid isomers in positive ion mode The LC-FAIMS-MS method for the 
determination of the steroid metabolites uses a HILIC separation with an analysis 
time of less than 10 minutes.  
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Experimental 
Chemicals 
HPLC grade acetonitrile (ACN), HPLC grade water (H2O), ammonium acetate, and 
sodium acetate were all purchased from Fisher Scientific (Loughborough, UK). 
Acetic acid was purchased from Sigma Aldrich (Dorset, UK), and cesium chloride 
was obtained from Riedel-de Haën (Seelze, Germany). Testosterone glucuronide 
(TG, 50 µg mL-1), epitestosterone glucuronide (ETG, 100 µg mL-1), etiocholanolone 
glucuronide (ECG, 87 µg mL-1), androsterone glucuronide (ADG, 100 µg mL-1), 
testosterone sulfate (TS, 77 µg mL-1), epitestosterone sulfate (ETS 76 µg mL-1) and 
dehydroepiandrosterone sulfate (DHEAS, solid) solutions in methanol, were supplied 
by the Drug Control Centre (King’s College London, London, UK). Anonymized urine 
samples were also supplied by the Drug Control Centre (King’s College London, 
London, UK) with the urinary supernatants then stored at -20 °C prior to analysis. 
Sample preparation 
Standard solutions of the steroid compounds for FAIMS-MS (2 µg mL-1) and LC-
FAIMS-MS analysis were prepared by dilution in the starting LC mobile phase 98:2 
v/v ACN:H2O with 10 mM ammonium acetate and 0.1% acetic acid, with the addition 
of sodium acetate (3.69 µg mL-1) for FAIMS-MS analysis. Standard solutions for LC-
FAIMS-MS and LC-MS analysis were prepared without the addition of sodium 
acetate. For spiking urine aliquots, the steroid standards were diluted in H2O and 
spiked (1 µg mL-1) into a pooled urine sample prior to sample clean-up. 
Investigations into the steroid metabolite FAIMS separation in the starting mobile 
phase were performed with the addition of sodium acetate (3.69 µg mL-1) and 
cesium chloride (0.34 µg mL-1).  
Aliquots of urine (500 µL), stored at -80 °C, were thawed for twenty minutes. The 
urine was diluted with H2O (500 µL) or, for spiked aliquots, a mixture of all seven 
steroids diluted in H2O was added (1 µg mL-1, 500 µL) and the diluted urine (1 mL) 
was centrifuged for 10 min at 10,000 g. A solid phase extraction (SPE) sample 
clean-up was employed, using a C18 cartridge (60 mg, Phenomenex, Macclesfield, 
UK) conditioned with ACN (1 mL) and equilibrated with H2O (1 mL). The diluted urine 
(1 mL) was loaded onto the SPE cartridge. The cartridge was washed with 14:86 v/v 
ACN:H2O (1 mL) before elution using ACN (2 mL). The eluent was evaporated to 
near dryness (~10 µL) at 30°C using a Turbovap LV concentration workstation 
(Caliper Life Sciences, Hopkinton, MA, USA) and reconstituted in 50 µL 98:2 v/v 
ACN:H2O with 10 mM ammonium acetate and 0.1% acetic acid. The reconstituted 
urine extract was transferred to a polypropylene micro-insert (Agilent Technologies, 
Santa Clara, USA) in an autosampler vial (2 mL) for LC-FAIMS-MS and LC-MS 
analysis.  
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Instrumentation 
LC-FAIMS-MS and LC-MS analyses of steroid metabolites were performed using an 
Agilent 1200 series HPLC coupled with an Agilent 6230 time-of-flight (TOF) mass 
spectrometer fitted with a JetStream electrospray ionisation (ESI) source operated in 
positive ion mode (Agilent Technologies, Santa Clara, USA). The miniaturized 
FAIMS device (ultraFAIMS, Owlstone Ltd.), with an electrode gap of 100 µm, a short 
trench length (78.1 mm) and ion path length (700 µm), which has been described 
elsewhere,18,19 was located in front of the inlet capillary of the mass spectrometer 
behind a modified spray shield in the ESI source. LC-MS analyses were performed 
with the FAIMS device in place and no electric field applied. FAIMS-MS analyses 
were performed by direct infusion, via a syringe pump (11-plus, Harvard Apparatus, 
Cambridge, UK), operated at a rate of 10 µL min-1.  
HPLC separation for LC-FAIMS-MS and LC-MS was carried out on an Agilent 
Poroshell 120 hydrophilic interaction liquid chromatography (HILIC) column (4.6 x 
50 mm, 2.7 µm), maintained at 35 °C, with a 5 mm HILIC guard column (Agilent 
Technologies, Santa Clara, USA) and a 5 µL sample injection volume (autosampler 
maintained at 6 °C). A gradient chromatographic method utilized mobile phase A 
consisting of H2O with 10 mM ammonium acetate and 0.1% acetic acid and mobile 
phase B consisting of 98:2 v/v ACN:H2O with 10 mM ammonium acetate and 0.1% 
acetic acid. The chromatographic method was as follows: hold at 100% B from 
0-0.5 min, decrease to 92% B at 1.5 min, decrease further to 82% B at 2.5 min and 
hold for 1 min, before increasing back up to 100% B at 6 min and holding for 2 min, 
for a total run time of 8 min and operated at a flow rate of 0.275 mL min-1. A solution 
of 205.1 µg mL-1 sodium acetate (in 90:10 v/v ACN:H2O) was infused into the LC 
mobile phase post-column at a flow rate of 5 µL min-1 in order to promote the 
formation of doubly sodiated adducts of the steroid metabolites in the ESI source 
(post LC separation, prior to FAIMS and MS).   
The scan rate of the TOF MS was 10 scans s-1 for FAIMS-MS analysis and 
2 scans s-1 for LC-FAIMS-MS and LC-MS analysis in the m/z range 80-1500 Da. The 
MS nebulizer pressure was set to 50 psig with a sheath gas (N2) flow of 11 L min-1 at 
250 °C, with a nozzle voltage of 2000 V. The capillary voltage was set to 3500 V, the 
fragmentor voltage was set to 200 V and the drying gas (N2) flow set to 7 L min-1 at 
150 °C, which also provides N2 as the carrier gas in the FAIMS device. FAIMS-MS 
analyses were performed using a two-dimensional FAIMS scan (or sweep) in the DF 
range from 180-300 Td (in steps of 10 Td) and CF range from -2-5 Td (in steps of 
0.05 Td). The FAIMS parameters were optimized for the seven metabolites and LC-
FAIMS-MS analyses were performed at three conditions (each at DF 260 Td) of CF 
1.35 Td for DHEAS, TS and TG, CF 2.05 Td for ETS, ETG and ECG, and CF 2.70 
Td for ADG (where 1 Td = 10-17 V cm2). The data were acquired in three analysis 
runs with the FAIMS at held static at one condition per run, however it is possible to 
acquire the data in one analysis by alternating between the FAIMS conditions, to 
allow for the determination of all seven steroid metabolites in a single run. Data were 
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acquired using Agilent MassHunter Acquisition B.05.00 and prototype FAIMS Control 
software, and processed using Agilent MassHunter Qualitative Analysis B.05.00. 
Microsoft Excel and OriginLab 2015 (Academic version b9.2.272).  
 
Results and Discussion 
FAIMS-MS investigation of steroid metabolites 
Preliminary FAIMS-MS analysis of TG/ETG showed no significant separation of the 
deprotonated isobaric steroid metabolites in negative ion mode (data not shown). 
However, there was a partial resolution observed in positive ion mode for the 
protonated and sodiated adducts. Therefore, a FAIMS-MS investigation into the 
separation of the seven steroid metabolites was conducted in positive ion mode to 
study the effects of different cations (H+, NH4+, Na+, K+, Cs+) on the FAIMS 
separation. Figure 2 is a summary of the variation of CF with the applied DF for the 
cationized steroid metabolites following direct infusion into the FAIMS-MS, where the 
CF values plotted are for the apex of the FAIMS peak at each DF; note that not all of 
the adduct ions were observed for each of the steroids. The FAIMS characteristics of 
the steroid ions result from differences between the complex non-linear relationship 
for ion mobility and field strength at high fields, compared to the field-independent 
ion mobility under low field conditions. Differential ion mobility is influenced by 
cationisation, so the appropriate choice of cation may result in the separation of 
isobaric ions where the protonated and deprotonated molecules are not 
resolved.8,20,21 
Separation of TG/ETG (Figure 2, dark blue/green) was observed for the protonated, 
sodiated and cesium adducts, with the best separation obtained for the doubly 
sodiated adducts, [TG+2Na-H]+ and [ETG+2Na-H]+. Separation of ADG/ECG (Figure 
2, red/grey) was only achieved for the sodiated and doubly sodiated adducts. The 
[ADG+Na]+ adduct was transmitted at lower CF values compared to [ECG+Na]+ for 
all DFs, but for the doubly sodiated adducts the order is reversed with the 
[ADG+2Na-H]+ adduct observed at higher CFs than [ECG+2Na-H]+.This results in 
better resolution of the doubly sodiated adducts in comparison to the singly sodiated 
ions, with peak widths of ~ 1Td allowing the ions to be transmitted at 2.05 Td (ECG) 
and 2.70 Td (ADG) without overlap. The sulfated steroid metabolites were generally 
detected as di-cations, except for the protonated forms of TS/ETS, which showed no 
separation (Figure 2, purple/light blue), and only small differences between the 
separation with the different metal cations were observed. In each case, the ETS 
(Figure 2, light blue) was separated from TS/DHEAS (Figure 2, purple/orange), with 
the greatest resolution observed for the [M+Na+K-H]+ adducts. TS/DHEAS were not 
separated by FAIMS for any combination of cations. 
The doubly sodiated adducts ([M+2Na-H]+) were selected for the LC-FAIMS-MS 
analysis, because of the separation of the steroid isobars, with post-column addition 
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of sodium acetate to promote the formation of sodiated adducts. A sodium 
concentration of 0.20 mg mL-1 provided the optimum sensitivity for the [M+2Na-H]+ 
ions, suppressing other adducts without promoting the formation of higher sodiated 
clusters.  For the combination of FAIMS with LC-MS, the FAIMS DF and CF 
separations of the doubly sodiated adducts were further investigated and optimized 
(Figure 3 (a)). As a compromise between separation and signal intensity, DF 260 Td 
was chosen from the FAIMS-MS analysis (Figure 3 (b)) to be used for all subsequent 
LC-FAIMS-MS analyses. Three optimum FAIMS CFs were selected (Figure 3 (b)) to 
transmit the steroid metabolites ([M+2Na-H]+): CF 1.35 Td for DHEAS, TS and TG; 
CF 2.05 Td for ETS, ETG and ECG; and CF 2.70 Td for ADG. This choice of FAIMS 
settings allowed the selective transmission of each of the glucuronide isobars in a 
mixture of the seven steroid standards. DHEAS and TS were not separated by 
FAIMS (same CF for transmission) or MS (same m/z), so it was necessary to 
achieve chromatographic separation of the DHEAS and TS in the LC-FAIMS-MS 
analysis. The relationship between the structures of steroid ions and their low field 
ion mobility has been reported for the separation of TG/ETG using TWIMS, and the 
resolution of the sodiated dimers of androsterone epimers by static field DTIMS.7,22 
However, relating structure to CF in FAIMS is more complicated due to the non-
linear relationship between ion mobility and field strength at high fields. This is 
dependent upon several factors including the effective temperature (determined by 
the carrier gas temperature and frictional heating), interactions between the ion and 
buffer gas and structural changes as the field is increased. Therefore modelling the 
CF values for these steroid metabolites was not attempted in this study.  
 
Determination of steroid metabolites using LC-FAIMS-MS  
Reversed-phase (C18) and HILIC chromatography were both investigated for the 
separation of the steroid metabolites. The glucuronides were chromatographically 
resolved using a reversed phase method, however DHEAS and TS were not 
resolved. The glucuronides were also separated by FAIMS, but DHEAS and TS were 
not, so the only combination found to be capable of separating all seven metabolites 
was HILIC-FAIMS-MS. A fast HILIC method (8 min) was selected due to the rapid 
elution of the three steroid sulfates (Figure 4 (a)), where TS/ETS co-elute 
(m/z 413.14, retention times 2.20/2.22 min respectively), but are chromatographically 
separated from DHEAS (m/z 413.14, retention time 1.93 min), as shown in Figure 4 
(a) (FAIMS off). As TS/ETS are separated by CF in the FAIMS, the combination of 
LC-FAIMS-MS allows separation of each of the steroid sulfates (Figure 4 (a), CFs 
1.35 Td and 2.05 Td). In LC-MS (Figure 4, FAIMS off) the glucuronides TG/ETG (m/z 
509.21, 7.23/7.09 min respectively) and ADG/ECG (m/z 511.23, 6.99/7.07 min 
respectively) co-elute, as shown in Figure 4 (b) and (c) respectively; therefore all of 
the steroid metabolites could not be identified and quantified using LC-MS alone. 
TG/ETG and ADG/ECG are selectively transmitted using the FAIMS at CFs 1.35 Td 
and 2.05 Td for TG/ETG (Figure 4 (b)) and CFs 2.05 Td and 2.70 Td for ECG/ADG 
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(Figure 4 (c)). LC-FAIMS-MS allows a high level of discrimination (>95%) for the 
steroid metabolites spiked into urine (Table 1) where discrimination was calculated 
from the peak areas of the spiked standards (1 µg mL-1) run individually and as a 
mixture using LC-FAIMS-MS at the three chosen CFs (DF 260 Td). Intra-day 
reproducibility of LC-FAIMS-MS of spiked standards (1 µg mL-1) was found to be 
comparable to LC-MS (%RSD <10%) with no internal standard used, as shown in 
Table 1 (note that for the LC-MS of TS/ETS and ADG/ECG, individual %RSDs could 
not be determined due to co-elution). Therefore, a three-dimensional separation of 
all seven of the targeted steroid metabolites was achieved through the incorporation 
of FAIMS with LC-MS with an analysis time of <10 minutes (Figure 5).  
The addition of sodium acetate to promote the formation of the doubly sodiated 
adducts of the steroid metabolites also results in the formation of singly charged 
clusters of the [M+2Na-H]+ adducts with sodium acetate of the formula [M+2Na-
H]++(NaOAc)n. These were observed in the mass spectra in MS and FAIMS-MS 
modes, and the mass spectra extracted from the chromatographic peak retention 
times for each steroid in LC-MS and LC-FAIMS-MS. Using MS alone, each of the 
steroid metabolites forms clusters with the sodium acetate ranging from one sodium 
acetate up to a cluster of thirteen (Supplementary Figures 1-3 (a)). In FAIMS-MS, 
different cluster patterns are observed for both the sulfates (Supplementary Figure 1 
(b)) and the glucuronides (Supplementary Figures 2 & 3 (b)). Further differences in 
the cluster pattern intensities can be observed in LC-FAIMS-MS (Supplementary 
Figures 1-3 (c & d)) in comparison to FAIMS-MS. The different cluster patterns 
observed for each steroid metabolite arise from the transmission of the clusters 
through the FAIMS device. For example, at the CF for transmission of ADG (CF 2.70 
Td, DF 260 Td) in the LC-FAIMS-MS (Supplementary Figure 3 (c & d)) none of the 
cluster ions with sodium acetate are observed as they all traverse the device at lower 
CF values, therefore the only ion observed is the doubly sodiated ion of ADG 
([ADG+2Na-H]+). However, the lower-ordered clusters for ECG are transmitted 
through the device at CF 2.05 Td (DF 260 Td). The cluster patterns of each of the 
sulfate ions in the LC-FAIMS-MS (Supplementary Figure 1 (c & d)) are highly diverse 
with clusters for DHEAS observed across the mass spectrum, higher ordered 
clusters for TS observed and lower ordered clusters for ETS observed; therefore, 
creating unique cluster patterns at the CFs for transmission of each ion. In tandem 
MS, a fragmentation pattern can be used to confirm the identity of species.23,24 Here 
we propose that using FAIMS, cluster patterns could be used as an additional 
qualifying identification tool to confirm the identity of each of the steroid metabolites 
utilizing the FAIMS pre-selection, either by FAIMS-MS or LC-FAIMS-MS.  
Table 2 shows the quantitative characteristics of the LC-FAIMS-MS method for the 
determination of standards of the seven steroids. Good linearity (R2 > 0.99) was 
observed in a six point calibration across the range 31-1000 ng mL-1 for each of the 
targeted doubly sodiated ions ([M+2Na-H]+) of the steroid metabolites. [ADD TEXT 
HERE] Limits of detection (LOD, S:N 3:1) were in the range 1-6 ng mL-1 and limits of 
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quantification (LOQ, S:N 10:1) in the range 3-20 ng mL-1. Internal standards were not 
used in not used in this LC-FAIMS-MS method development, but could be 
incorporated in routine assays. These data demonstrate the stability of the 
miniaturized FAIMS and ion source configuration used in this study, although the 
CFs for ion transmission would require optimization for other FAIMS chip and ion 
source configurations. Using LC-MS alone without the FAIMS, some of the steroid 
metabolites could not be quantified using this chromatographic method without a 
significantly increased chromatographic run time due to the co-elution of the isobaric 
steroid metabolites.  
LC-FAIMS-MS in comparison to LC-MS has been shown previously to increase 
linear dynamic ranges and lower LODs and LOQs due to S:N improvements of 
components of interest resulting from a reduction in chemical noise.25 This was 
demonstrated for the targeted steroid metabolites investigation in unspiked human 
urine. Figure 6 demonstrates the determination of ADG/ECG in urine by LC-MS and 
LC-FAIMS-MS. Using LC-FAIMS-MS the two isobars are individually identified and 
S:N improvements of >250% are observed (ADG S:N 1450, ECG S:N 4510) 
compared to the unresolved ADG/ECG peaks in LC-MS (S:N 180). Increases in the 
S:N for components using LC-FAIMS-MS is advantageous as they can lead to lower 
LODs and LOQs, enhancing the response of targeted components by reducing noise 
and removing isobaric interferences from the matrix. 
 
Conclusions 
The combination of a miniaturized FAIMS separation with LC-MS using a HILIC 
column has enabled the determination of seven anabolic steroid metabolites in 
human urine. A short chromatographic run time (8 min) was made possible by 
FAIMS separation of co-eluting isobaric steroid metabolites. A reduction in chemical 
noise from the urine matrix and improved S:N is also observed. The LC-FAIMS-MS 
method showed good qualitative and quantitative responses for the steroid 
metabolites, with an additional identification tool using cluster patterns made 
possible using FAIMS. Higher sensitivity for the naturally low-abundant steroid 
metabolites could be achieved by combining the LC-FAIMS-MS with tandem mass 
spectrometry, for example a triple quadrupole mass spectrometer.  
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Figures 
 
Figure 1: Structures of the targeted steroid metabolites (a) testosterone and epitestosterone 
glucuronides (TG/ETG), (b) etiocholanolone and androsterone glucuronides (ECG/ADG), 
and (c) testosterone, dehydroepiandrosterone and epitestosterone sulfates (TS, DHEAS and 
ETS) 
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Figure 2: FAIMS-MS analysis of steroid metabolite adducts; plotted are the CF values for the 
apex of each FAIMS peak signal intensity for each DF (10 Td steps) for ADG (red), DHEAS 
(orange), ECG (grey), ETG (green), ETS (light blue), TG (dark blue) and TS (purple) 
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Figure 3: (a) FAIMS-MS DF vs. CF waterfall plot for the seven targeted steroid metabolites in 
98:2 v/v ACN:H2O with 10 mM ammonium acetate and 0.1% acetic acid; (b) CF plot at DF 
260 Td with three optimized CFs 1.35 Td, 2.05 Td and 2.70 Td 
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Figure 4: Mass extracted ion chromatograms for the seven steroids spiked (1 µg mL-1) into 
urine with LC-MS (FAIMS off) shown in black and LC-FAIMS-MS chromatograms (at DF 260 
Td) with the optimum CFs chosen for each steroid: CF 1.35 Td (purple) for DHEAS (a) and 
TS (a) (m/z 413.14) and TG (b) (m/z 509.21); CF 2.05 Td (pink) for ETS (a) (m/z 413.14), 
ETG (b) (509.21) and ECG (c) (m/z 511.23); and CF 2.70 Td (grey) for ADG (c) (m/z 511.23) 
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Figure 5: Summary of the three-dimensional separation achieved for seven steroid 
metabolites using LC-FAIMS-MS, where isobaric steroids are color coded: m/z 413.14 
(purple), m/z 509.21 (pink), and m/z 511.23 (grey)  
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Table 1: Discrimination (%) between steroid metabolites, calculated as 
[Areaindividual/Areamixed]x100, and relative standard deviations (%) for LC-MS and LC-FAIMS-
MS analysis of spiked urine replicate aliquots (n = 6) 
 
 
 
Table 2: Summary of the quantitative responses for the steroid metabolites using LC-FAIMS-
MS  
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Figure 6: Extracted ion chromatographs (m/z 511.23, DF 260 Td) for unspiked urine with LC-
MS (black) and LC-FAIMS-MS at CF 2.05 Td (pink, ECG) and at CF 2.70 Td (grey, ADG). 
S:N improvement of >250% are observed 
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 Supplementary Figure 1: Cluster patterns observed in the mass spectra for the doubly 
sodiated [M+2Na-H]+ ions of DHEAS/TS/ETS (m/z 413.137) analyzed individually using (a) 
MS, (b) FAIMS-MS (DF 260 Td, CF 1.35 Td (DHEAS/TS) and CF 2.05 Td (ETS)) and (c) LC-
FAIMS-MS; (d) LC-FAIMS-MS for DHEAS/TS/ETS analyzed as a mixture 
 
 Supplementary Figure 2: Cluster patterns observed in the mass spectra for the doubly 
sodiated [M+2Na-H]+ ions of TG/ETG (m/z 509.212) analyzed individually using (a) MS, (b) 
FAIMS-MS (DF 260 Td, CF 1.35 Td (TG) and CF 2.05 Td (ETG)) and (c) LC-FAIMS-MS; (d) 
LC-FAIMS-MS for TG/ETG analyzed as a mixture 
 Supplementary Figure 3: Cluster patterns observed in the mass spectra for the doubly 
sodiated [M+2Na-H]+ ions of ADG/ECG (m/z 511.228) analyzed individually using (a) MS, 
(b) FAIMS-MS (DF 260 Td, CF 2.70 Td (ADG) and CF 2.05 Td (ECG)) and (c) LC-FAIMS-
MS; (d) LC-FAIMS-MS for ADG/ECG analyzed as a mixture 
 
 
 
 
 
 
 
 
 
